Prime Medicine Inc. (PRME)
NASDAQ: PRME
· Real-Time Price · USD
3.56
-0.08 (-2.20%)
At close: Aug 15, 2025, 3:59 PM
3.60
0.98%
After-hours: Aug 15, 2025, 05:32 PM EDT
Prime Medicine Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 4.96M | 41.62M | 40.76M | 38.57M | 38.37M | 591K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.13M | 9.13M | 9.13M | 9.13M | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.57M | 9.13M | 9.13M | 9.13M | 4.57M |
Gross Profit | 3.85M | 41.62M | 40.17M | 37.98M | 37.77M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.57M | n/a | n/a | n/a | -4.57M |
Operating Income | -204.22M | -206.52M | -202.47M | -226.29M | -223.51M | -213.1M | -204.79M | -175.44M | -155.63M | -136.68M | -116.54M | -137.93M | -116.71M | -98.42M | -84.47M | -26.57M | -16.14M | -10.3M |
Interest Income | 4.16M | 4.03M | 2.85M | 1.31M | 611K | 635K | 635K | 635K | 635K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -199.28M | -202.15M | -195.88M | -219.25M | -217.55M | -204.44M | -198.41M | -172.24M | -150.56M | -138M | -122.77M | -144.83M | -134.47M | -102.95M | -165.85M | -106.85M | -88.07M | -92.33M |
Net Income | -199.28M | -202.01M | -195.88M | -219.25M | -217.44M | -204.5M | -198.13M | -171.77M | -156.78M | -150.03M | -140.7M | -162.86M | -149.92M | -113.67M | -170.26M | -111.35M | -88.57M | -91.72M |
Selling & General & Admin | 52.8M | 52.29M | 50.16M | 50.94M | 47.34M | 45.39M | 43.39M | 39.93M | 36.04M | 32.75M | 29.82M | 27.38M | 23.8M | 18.76M | 13.92M | 7.99M | 4.96M | 3.89M |
Research & Development | 156.38M | 158.08M | 155.29M | 162.64M | 163.27M | 154.8M | 147.91M | 135.51M | 119.59M | 103.93M | 86.72M | 110.55M | 92.91M | 79.66M | 70.55M | 18.58M | 11.18M | 6.41M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 238K | 249K | 261K | 260K | -4.54M | -9.12M | -9.13M | -9.13M | -4.57M |
Operating Expenses | 209.18M | 210.36M | 205.45M | 213.59M | 210.61M | 200.19M | 191.29M | 175.44M | 155.63M | 136.68M | 116.54M | 137.93M | 116.71M | 93.85M | 75.34M | 17.44M | 7.01M | 5.73M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 154.69M | 210.36M | 205.45M | 213.59M | 210.61M | 200.19M | 191.29M | 175.44M | 155.63M | 136.68M | 116.54M | 137.93M | 116.71M | 98.42M | 84.47M | 26.57M | 16.14M | 10.3M |
Income Tax Expense | n/a | -134K | n/a | 558K | 450K | 615K | 279K | -465K | -145K | -618K | -948K | 619K | -1.96M | -403K | -486K | -1.86M | 507K | -607K |
Shares Outstanding (Basic) | 129.19M | 130.88M | 118.6M | 119.76M | 119.19M | 104.47M | 97.38M | 91.85M | 90.47M | 89.06M | 71.79M | 94.34M | 71.8M | 71.8M | 71.8M | 71.8M | 95.73M | 83.76M |
Shares Outstanding (Diluted) | 129.19M | 130.88M | 118.6M | 119.76M | 119.19M | 104.47M | 97.38M | 91.85M | 90.47M | 89.06M | 74.19M | 94.34M | 71.8M | 71.8M | 71.8M | 71.8M | 13.04M | 7.33M |
EPS (Basic) | -1.6 | -1.65 | -1.69 | -2.01 | -2.12 | -2.13 | -2.13 | -2.03 | -1.86 | -1.89 | -1.87 | -2.26 | -2.2 | -1.74 | -2.35 | -1.43 | -1.11 | -1.11 |
EPS (Diluted) | -1.6 | -1.65 | -1.69 | -2.01 | -2.12 | -2.13 | -2.13 | -2.01 | -1.84 | -1.87 | -1.85 | -2.26 | -2.2 | -2.02 | -13.58 | -12.66 | -12.34 | -12.06 |
EBITDA | -199.25M | -200M | -196.34M | -207.13M | -204.68M | -194.68M | -186.64M | -171.16M | -151.96M | -133.7M | -114.32M | -136.35M | -115.59M | -97.61M | -83.91M | -24.73M | -14.47M | -8.75M |
EBIT | -150.85M | -206.52M | -202.47M | -212.79M | -210.01M | -199.6M | -191.29M | -175.44M | -155.63M | -136.68M | -116.54M | -137.93M | -116.71M | -98.42M | -84.47M | -25.1M | -14.67M | -8.82M |
Depreciation & Amortization | 4.97M | 6.51M | 6.13M | 5.66M | 5.34M | 4.92M | 4.65M | 4.28M | 3.67M | 2.98M | 2.22M | 1.58M | 1.12M | 811K | 568K | -14K | -181K | -303K |